Methylenedioxybutylamphetamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
MDBU, also known as 3,4-methylenedioxy-N-butylamphetamine or as N-butyl-MDA, is a lesser-known drug.[1][2] It is the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1][2]
Other namesMDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA
ATC code
- None
Duration of actionUnknown[1]
| Clinical data | |
|---|---|
| Other names | MDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
Chemistry
Synthesis
The chemical synthesis of MDBU has been described.[1]